tiprankstipranks
Nu Skin Enterprises (NUS)
NYSE:NUS
Holding NUS?
Track your performance easily

Nu Skin (NUS) Stock Price & Analysis

414 Followers

NUS Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Business InnovationNUS is working to stimulate its core business with innovation, such as MYND360 and affordable luxury, and refreshed business models in select markets.
Cost ManagementCost savings initiatives, accelerated SKU rationalization plan, and promo/discount management are viewed positively.
ValuationValuation now looks more reasonable and is consistent with a lower-for-longer topline outlook following recent re-rating.
Bears Say
Financial GuidanceThe company lowered net sales and EPS guidance due to pressure from tough macroeconomic conditions, greater foreign exchange headwinds, and increased expenses.
Market PerformanceThe stock is down about 40% since reporting results, reflecting weaker macroeconomic conditions and removal from the S&P 600 index.
Sales OutlookThe sales outlook has worsened as macroeconomic conditions and beauty category trends have softened.
---

Financials

Annual

Ownership Overview

2.02%19.14%0.38%60.19%
0.38% Other Institutional Investors
60.19% Public Companies and Individual Investors

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

NUS FAQ

What was Nu Skin Enterprises’s price range in the past 12 months?
Nu Skin Enterprises lowest stock price was $5.95 and its highest was $19.30 in the past 12 months.
    What is Nu Skin Enterprises’s market cap?
    Nu Skin Enterprises’s market cap is $344.50M.
      When is Nu Skin Enterprises’s upcoming earnings report date?
      Nu Skin Enterprises’s upcoming earnings report date is Feb 13, 2025 which is in 26 days.
        How were Nu Skin Enterprises’s earnings last quarter?
        Nu Skin Enterprises released its earnings results on Nov 07, 2024. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.197 by -$0.027.
          Is Nu Skin Enterprises overvalued?
          According to Wall Street analysts Nu Skin Enterprises’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Nu Skin Enterprises pay dividends?
            Nu Skin Enterprises pays a Quarterly dividend of $0.236 which represents an annual dividend yield of 3.46%. See more information on Nu Skin Enterprises dividends here
              What is Nu Skin Enterprises’s EPS estimate?
              Nu Skin Enterprises’s EPS estimate is 0.22.
                How many shares outstanding does Nu Skin Enterprises have?
                Nu Skin Enterprises has 49,711,020 shares outstanding.
                  What happened to Nu Skin Enterprises’s price movement after its last earnings report?
                  Nu Skin Enterprises reported an EPS of $0.17 in its last earnings report, missing expectations of $0.197. Following the earnings report the stock price went up 1.562%.
                    Which hedge fund is a major shareholder of Nu Skin Enterprises?
                    Among the largest hedge funds holding Nu Skin Enterprises’s share is Hotchkis & Wiley Capital Management LLC. It holds Nu Skin Enterprises’s shares valued at 4M.
                      ---

                      Company Description

                      Nu Skin Enterprises

                      Nu Skin Enterprises, Inc. develops and distributes personal care products and nutritional supplements. The firm engages in the provision of beauty and wellness products and solutions. Its brands include Nu Skin and Pharmanex. The company was founded by Blake M. Roney, Sandra N. Tillotson, and Steven J. Lund in 1984 and is headquartered in Provo, UT.
                      ---

                      NUS Company Deck

                      ---

                      NUS Earnings Call

                      Q3 2024
                      0:00 / 0:00
                      Earnings Call Sentiment|Neutral
                      The earnings call presented a mix of positive developments and significant challenges. While the Rhyz segments and operational efficiency efforts show promise, the overall decline in revenue and challenges in key markets are concerning. The sentiment reflects a cautious approach towards future stabilization and growth, with strategic efforts focused on long-term vision amidst current headwinds.Read More>
                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      e.l.f. Beauty
                      Inter Parfums
                      Helen Of Troy
                      Beauty Health
                      Medifast
                      Popular Stocks
                      ---
                      What am I Missing?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis